Skip to content
OpenCapital
Get started

PMV Pharmaceuticals PMVP Q4 2024 Annual earnings

Reported March 3, 2025 · Before market open

Diluted EPS-$0.45Miss by $0.07
EPS estimate-$0.38

Next report

Aug 6, 2026 (In 3 weeks)
EPS estimate-$0.38

Versus estimates

Diluted EPS

Q1 2026-$0.34Beat by $0.07Q4 2025-$0.34Beat by $0.06Q3 2025-$0.40In lineQ2 2025-$0.41Miss by $0.02Q1 2025-$0.34Beat by $0.03
Q4 2024-$0.45Miss by $0.07

Ask the moment PMV Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PMV Pharmaceuticals report Q4 2024 earnings?
PMV Pharmaceuticals (PMVP) reported Q4 2024 earnings on March 3, 2025 before market open.
What were PMV Pharmaceuticals's Q4 2024 revenue and EPS?
PMV Pharmaceuticals reported diluted EPS of $-0.45 for Q4 2024.
Did PMV Pharmaceuticals beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.38 by $0.07.
Where can I find PMV Pharmaceuticals's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-030414) directly on SEC EDGAR. The filing index links above go to sec.gov.